These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Modifications of electroencephalographic tracings caused by reserpine]. COLOMBATI S Arch Psicol Neurol Psichiatr; 1956; 17(2-3):569-80. PubMed ID: 13341425 [No Abstract] [Full Text] [Related]
3. [Electroencephalographic modifications induced by reserpine in man]. DE CARO D Arch Psicol Neurol Psichiatr; 1956; 17(2-3):581-91. PubMed ID: 13341426 [No Abstract] [Full Text] [Related]
4. [Electroencephalographic variations from reserpine in neuropsychiatry]. MARTELLI G Arch Psicol Neurol Psichiatr; 1956; 17(2-3):595-6. PubMed ID: 13341428 [No Abstract] [Full Text] [Related]
5. Scalp and basal electroencephalogram during the effect of reserpine. ARELLANO AP; JERI R AMA Arch Neurol Psychiatry; 1956 May; 75(5):525-33. PubMed ID: 13312736 [No Abstract] [Full Text] [Related]
6. [Effects of reserpine on the electroencephalographic and motor reactions induced by stimulation of the hypothalamus]. LONGO VG; NAPOLITANO L Farmaco Sci; 1955; 10(6):297-305. PubMed ID: 13262093 [No Abstract] [Full Text] [Related]
7. [The effects of high-dosed reserpin (serpasil) treatment and drug-induced parkinsonism-like states on the electroencephalogram]. BENTE D; ITIL T Med Klin; 1955 Aug; 50(31):1296-301. PubMed ID: 13265093 [No Abstract] [Full Text] [Related]
8. Evaluation of growth promoting effect of total Rauwolfia extract and its alkaloid reserpine. KOHLI RP; PANDE LM; KISHORE K; GUJRAL ML Indian J Psychol; 1958 Apr; 2(2):374-80. PubMed ID: 13562909 [No Abstract] [Full Text] [Related]
9. [Combined effects of the Rauwolfia alkaloids reserpine and raubasine]. KRONEBERG G; GRAF K; OVERBECK W Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 228(1-2):169-71. PubMed ID: 13334602 [No Abstract] [Full Text] [Related]
10. Sites of action of the total alkaloids of Rauwolfia and reserpine on the sleep centre. FROMMEL E; GOLD P Acta Pharmacol Toxicol (Copenh); 1957; 13(4):345-56. PubMed ID: 13443996 [No Abstract] [Full Text] [Related]
11. [Pharmacological properties of the Rauwolfia alkaloid serpentina and of a combination of reserpine and serpentina (vilescon)]. KADATZ R Arzneimittelforschung; 1955 Dec; 5(12):715-9. PubMed ID: 13293078 [No Abstract] [Full Text] [Related]
12. [Rauwolfia serpentina. I. Comparative studies on the effects of reserpine and serpentine]. BILECKI G; JUST W; WEIDEL E Z Gesamte Inn Med; 1955 Dec; 10(23-24):1097-104. PubMed ID: 13312419 [No Abstract] [Full Text] [Related]
13. [Physiopathological and clinical therapeutic effects of reserpine. II. Somatic modifications during prolonged therapy and with massive doses]. RICCI GC; RICORDATI M Arch Psicol Neurol Psichiatr; 1956; 17(2-3):217-49. PubMed ID: 13341391 [No Abstract] [Full Text] [Related]
17. [Variations in coronary flow and the degree of contractions induced in the isolated mammalian heart by aminophylline, reserpine and whole Rauwolfia reserpentina alkaloids]. BIANCHI C Farmaco Sci; 1955; 10(10):779-82. PubMed ID: 13294159 [No Abstract] [Full Text] [Related]
18. [Somatic effects and psychiatric use of reserpine]. MASINI A; PESCETTO G; TOSCA L Arch Psicol Neurol Psichiatr; 1956; 17(2-3):249-56. PubMed ID: 13341392 [No Abstract] [Full Text] [Related]
19. Further characterization of central effects of reserpine (serpasil). SCHNEIDER JA Am J Physiol; 1955 Apr; 181(1):64-8. PubMed ID: 14376571 [No Abstract] [Full Text] [Related]
20. [Modifications induced by prolonged reserpine treatment on psychic symptomatology and behavior in chronic schizophrenia]. SANTANGELO G Arch Psicol Neurol Psichiatr; 1956; 17(2-3):388-93. PubMed ID: 13341405 [No Abstract] [Full Text] [Related] [Next] [New Search]